Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases
Rev. Soc. Bras. Med. Trop
; 46(4): 525-527, Jul-Aug/2013. tab
Article
en En
| LILACS
| ID: lil-683332
Biblioteca responsable:
BR1.1
ABSTRACT
Artemisinin-based combination therapy-resistant malaria is rare in Sub-Saharan Africa. The World Health Organization identifies monitoring and surveillance using day-3 parasitaemia post-treatment as the standard test for identifying suspected artemisinin resistance. We report three cases of early treatment failure due to possible artemisinin-based combination therapy-resistant Plasmodium falciparum malaria. All cases showed adequate clinical and parasitological responses to quinine. This study reveals a need to re-evaluate the quality and efficacy of artemisinin-based combination therapy agents in Nigeria and Sub-Saharan Africa.
Palabras clave
Texto completo:
1
Índice:
LILACS
Asunto principal:
Quinina
/
Malaria Falciparum
/
Artemisininas
/
Antimaláricos
Tipo de estudio:
Prognostic_studies
Límite:
Adult
/
Female
/
Humans
País/Región como asunto:
Africa
Idioma:
En
Revista:
Rev. Soc. Bras. Med. Trop
Asunto de la revista:
MEDICINA TROPICAL
Año:
2013
Tipo del documento:
Article